BCYC - Bicycle Therapeutics plc -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg ยท closes rebased to 100 at each year's first session
Ticker Details
Bicycle Therapeutics plc
IPO Date: May 20, 2019
Sector: Healthcare
Industry: Biotech
Market Cap: $261.07M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.61 | 3.20%
Avg Daily Range (30 D): $0.13 | 3.40%
Avg Daily Range (90 D): $0.10 | 2.54%
Institutional Daily Volume
Avg Daily Volume: .24M
Avg Daily Volume (30 D): .43M
Avg Daily Volume (90 D): .41M
Trade Size
Avg Trade Size (Sh.): 97
Avg Trade Size (Sh.) (30 D): 142
Avg Trade Size (Sh.) (90 D): 120
Institutional Trades
Total Institutional Trades: 1,056
Avg Institutional Trade: $2.02M
Avg Institutional Trade (30 D): $.67M
Avg Institutional Trade (90 D): $1.57M
Avg Institutional Trade Volume: .09M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.19M
Avg Closing Trade (30 D): $.57M
Avg Closing Trade (90 D): $.57M
Avg Closing Volume: 47.27K
 
News
Apr 21, 2026 @ 8:31 AM
Peptide Drug Conjugate Market Landscape Report 202...
Source: Researchandmarkets.Com
Aug 29, 2025 @ 7:49 AM
Bicycle Toxin Conjugates Clinical Trials FDA Appro...
Source: Globe Newswire
Aug 27, 2025 @ 12:00 PM
Maxion Therapeutics Strengthens Board with Appoint...
Source: Maxion Therapeutics
Mar 3, 2025 @ 6:00 PM
Advanced Urothelial Carcinoma Clinical Trial Pipel...
Source: Delveinsight
Jun 27, 2024 @ 1:40 PM
Are Medical Stocks Lagging Bicycle Therapeutics (...
Source: Zacks Equity Research
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-.72 $-.87
Diluted EPS $-.72 $-.87
Revenue $.63M $.89M
Gross Profit
Net Income / Loss $-50.33M $-60.83M
Operating Income / Loss $-54.56M $-65.48M
Cost of Revenue
Net Cash Flow
PE Ratio